Thailand Shows How to Cut Medicines Costs

Countries across Southeast Asia face rising rates of non-communicable diseases (NCDs). NCDs like heart disease, diabetes and cancer are the leading cause of death in the region. The government of Thailand is taking action to cut the cost of critical treatments for patients by eliminating unnecessary tariffs and exposing hospital markups.

APEC trade ministers reaffirm open, rules-based trade flows

Trade is essential to the economies of Southeast Asia. Our region is highly dependent on an open flow of rules-based commerce and cross-border investment to drive economic growth and improve livelihoods. At their recent virtual ministerial meeting, the trade ministers of the Asia-Pacific Economic Cooperation (APEC) reaffirmed the “the importance of a free, open, fair, non-discriminatory, transparent and predictable trade and investment environment to drive economic recovery at such a challenging time.”

COVID-19 Clinical Development Advancements in Southeast Asia

Clinical trials are a critical phase in the development of any new medicine. They are vital to determining the impact the treatment may have on patients. Since the beginning of the COVID-19 pandemic, clinical researchers throughout Southeast Asia have been working rapidly to test investigational medicines and identify possible vaccine candidates that may treat patients and prevent further spread of the virus.

What They Are Saying: IP Protections Critical to Combatting COVID-19 in Southeast Asia

The global biopharmaceutical industry relies on strong intellectual property (IP) rights to promote the development of breakthrough treatments and cures for patients. Innovation, underpinned by reliable IP protections, is now more important than ever as the private sector works around the clock to develop solutions to help prevent infection and treat patients with COVID-19, a